Find a Provider

In the Media

The Procedure that is Creating Buzz

” For patients who have longed for a solution to sagging facial skin and wrinkles without going under the knife, micro-coring is the new sparkly toy on the shelf. “

” Microneedling, microdermabrasion, microblading… That’s a lot of micros to keep straight, but some experts say micro-coring is unlike anything else in the category.  “

” This definitely sounds like a dream come true for those who are too tired of injectable touch-ups or take exception to the risks that come with surgeries. “

” Micro-coring can help rejuvenate the skin by stimulating the production of collagen, which a surgical facelift cannot. “

” Micro-coring has the added benefit of removing dermal tissue, rather than displacing it. “

” Those tiny chunks force the skin to go into overdrive producing more collagen and elastin to heal them (don’t worry, they’re microscopic so they don’t cause scars). Think of it as sitting somewhere between microneedling and a face lift. “

” Fort Lauderdale, FL dermatologist Dr. Matthew Elias agrees and says it is probably the only thing that really works nonsurgically for all patients. “

Cision PR Newswire / March 2023

Cytrellis® Biosystems Reaches New Milestone with 100th ellacor® System Delivered

Read More
Cision PR Newswire / February 2023

Cytrellis Biosystems Achieves Milestone with 1000th ellacor® Procedure Completed

Read More
PRiME / February 2023

What Aesthetics Doctors Are Excited About in 2023

Read More
Practical Dermatology / January 2023

Five Hot Things Patients Are Asking For This Winter

Read More
NewBeauty / January 2023

5 Skin Boosters For Smoother, Plumper, Tighter And Brighter Skin

Read More
The Palm Beach Post / January 2023

Minimal Invasive Treatments That Are Permanent

Read More
Dujour / January 2023

New to Market

Read More
Modern Aesthetics / December 2022

Coming & Going: November/December 2022

Read More
Healio / December 2022

Most Read Dermatology Articles of 2022

Read More
Dermatology Times / November 2022

New Tech for Skin

Read More
MDedge / October 2022

First-in-class device for facial wrinkles, tightening hits the market

Read More
New York Post / October 2022

How I got rid of my wrinkles without Botox, fillers, or surgery

Read More
Haute Living / October 2022

The Effects of Chronic Sun Exposure Are Not Hot Here – Here’s How To Reverse Them

Read More
New Beauty / October 2022

The Biggest Anti-Aging and Skin Care Buzz at the 2022 ASDS Meeting

Read More
Allure / August 2022

7 Non-Surgical Treatments to Firm Loose Skin, Recommended by Dermatologists

Read More
InStyle / April 2022

Meet Micro-Coring, the Non-Invasive Anti-Aging Treatment That Gets Rid of Wrinkles and Loose Skin

Read More
ELLE / November 2021

Need a Lift?

Read More
Harper’s Bazaar / May 2022

The No-Knife Face-Lift You Should Know About

Read More
Aedit / March 2022

Does Non-Surgical Micro-Coring Rival A Surgical Facelift?

Read More
Allure / November 2021

7 In-Office Treatments to Try If You’re Not a Fan of Injectables

Read More
Byrdie / December 2021

This Is Where Beauty Is Headed in 2022

Read More
WSJ Magazine / January 2022

One Jawline That Can Cut Glass, Please

Read More
RealSelf / December 2021

The 7 Buzziest Cosmetic Treatment Launches of 2022

Read More
Town & Country / April 2022

The T&C 2022 Procedure Guide

Read More


The ellacor® System with Micro-Coring® technology is indicated for use by medical professionals for the treatment of moderate and severe wrinkles in the mid and lower face in adults aged 22 years or older with Fitzpatrick skin types I-IV.

Important Safety Information


Your medical professional will discuss the following side effects with you prior to treatment. Proper pre- and post-treatment care reduces the risk of these side effects; however, some conditions may or may not resolve over time. Side effects associated with this procedure may include: redness, swelling, bruising, burning, dryness, roughness, tightness/pulling of skin, crusting, pain/discomfort, tenderness, tingling, bleeding, numbness, skin peeling, or circular marks on skin.

Other side effects not commonly observed with this procedure may include: itching, hyper/hypo pigmentation, hematoma, infection, scarring, skin irregularities, skin necrosis, uneven appearance of the treated regions (left and right sides of face), or anesthesia toxicity (anesthesia-related complications may include allergic reaction and possibly death).


The ellacor® procedure should not be used for the treatment of areas of skin with dermatosis (e.g. skin tumors, keloids or in case of predisposition to keloids, solar keratosis, warts, or birthmarks), area within the bony orbital rim; mucous membranes; areas where silicone or synthetic material is implanted.
The ellacor® procedure should not be used on patients that are pregnant or nursing mothers, suffering from open wounds, sores, or irritated skin in the treatment area, have an allergy to stainless steel or allergy to topical, oral, or injected medications or preparations that may be used during the procedure, such as petrolatum, lidocaine, bupivacaine, chlorhexidine, or povidone-iodine. Patients that have a history or presence of any clinically significant bleeding disorder, have dermatological or autoimmune conditions that may affect the treatment outcome; these may include, but are not limited to: actinic keratosis, raised nevi, rosacea, melasma, active acne, cutaneous papules/nodules, active inflammatory lesions, dermatitis, psoriasis, cellulitis, urticarial folliculitis, acute inflammatory phase of scleroderma, rheumatoid arthritis, eczema, psoriasis, allergic dermatitis, collagen disorders, or lupus should not be treated with the ellacor® procedure. Additionally, patients that have systemic infections or acute local skin infections such as Hepatitis disorders type A, B, C, D, E or F or HIV infection, take a high dose of anti-coagulants or blood-thinning substances (e.g. aspirin, nonsteroidal anti-inflammatory drugs, NSAIDs, warfarin, heparin, acetylsalicylic acid during the previous fourteen (14) days), are on courses of chemotherapy, high-dose corticosteroid use, or radiation in the treatment area, have undergone plastic surgery of the face within the last twelve (12) months or have any facial surgical scars less than twelve (12) months old, have undergone injections of dermal fillers, fat, or botulinum toxin, as well as any minimally invasive/invasive skin treatment in the treatment area during the previous six (6) months, or have scars less than six (6) months old in the treatment area should not be treated with the ellacor® procedure.


Appropriateness for treatment is based on the clinical assessment of the patient by the treating physician. Use caution when treating patients with the following conditions or taking the following medications:

  • History of hyperpigmentation
  • Recent exposure to sun or tanning beds with red, peeling, or swollen skin
  • Active, chronic, or recurrent infection including bacterial or fungal infections
  • History of active herpes simplex infection in the treatment area
  • Use of topical or oral preparations/medications that may change the skin integrity or prolong healing
  • Over the Counter (OTC) and herbal supplements that may increase the risk of bleeding or prolong healing, such as gingko biloba, garlic, ginseng, dong quai, fever few, and fish oil
  • Other medications or medical conditions that may interfere with the treatment or that the treatment provider believes may compromise the safety of the patient or the efficacy of the treatments. Refer the patient to their Primary Care Physician (PCP) or other managing health care provider or clearance prior to treatment
  • Recent trauma or surgery to the treatment area